Global Rivaroxaban Sales Market Report 2016

October 2016 | 128 pages | ID: G14C8EF8808EN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Rivaroxaban

Revenue, means the sales value of Rivaroxaban

This report studies sales (consumption) of Rivaroxaban in Global market, especially in USA, China, Europe, Japan, India and Southeast Asia, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering

• Pfizer, Inc. (US)
• Bayer Healthcare AG (Germany)
• GlaxoSmithKline Plc. (UK)
• Boehringer Ingelheim (Germany)
• Sanofi S.A. (France)
• Abbott India Limited (India)
• Aspen Holdings (South Africa)
• Bristol-Myers Squibb Company (US)
• Eisai Inc. (US)
• Mitsubishi Tanabe Pharma Corporation (Japan)
• Teva Pharmaceutical Industries Ltd. (Israel)

Market Segment by Regions, this report splits Global into several key Regions, with sales (consumption), revenue, market share and growth rate of Rivaroxaban in these regions, from 2011 to 2021 (forecast), like

• USA
• China
• Europe
• Japan
• India
• Southeast Asia

Split by product Types, with sales, revenue, price and gross margin, market share and growth rate of each type, can be divided into

• Type I
• Type II
• Type III

Split by applications, this report focuses on sales, market share and growth rate of Rivaroxaban in each application, can be divided into

• Application 1
• Application 2
• Application 3

Contents

Global Rivaroxaban Sales Market Report 2016

1 RIVAROXABAN OVERVIEW

1.1 Product Overview and Scope of Rivaroxaban
1.2 Classification of Rivaroxaban
  1.2.1 Type I
  1.2.2 Type II
  1.2.3 Type III
1.3 Application of Rivaroxaban
  1.3.1 Application
  1.3.2 Application
  1.3.3 Application
1.4 Rivaroxaban Market by Regions
  1.4.1 USA Status and Prospect (2011-2021)
  1.4.2 China Status and Prospect (2011-2021)
  1.4.3 Europe Status and Prospect (2011-2021)
  1.4.4 Japan Status and Prospect (2011-2021)
  1.4.5 India Status and Prospect (2011-2021)
  1.4.6 Southeast Asia Status and Prospect (2011-2021)
1.5 Global Market Size (Value and Volume) of Rivaroxaban (2011-2021)
  1.5.1 Global Rivaroxaban Sales and Growth Rate (2011-2021)
  1.5.2 Global Rivaroxaban Revenue and Growth Rate (2011-2021)

2 GLOBAL RIVAROXABAN COMPETITION BY MANUFACTURERS, TYPE AND APPLICATION

2.1 Global Rivaroxaban Market Competition by Manufacturers
  2.1.1 Global Rivaroxaban Sales and Market Share of Key Manufacturers (2011-2016)
  2.1.2 Global Rivaroxaban Revenue and Share by Manufacturers (2011-2016)
2.2 Global Rivaroxaban (Volume and Value) by Type
  2.2.1 Global Rivaroxaban Sales and Market Share by Type (2011-2016)
  2.2.2 Global Rivaroxaban Revenue and Market Share by Type (2011-2016)
2.3 Global Rivaroxaban (Volume and Value) by Regions
  2.3.1 Global Rivaroxaban Sales and Market Share by Regions (2011-2016)
  2.3.2 Global Rivaroxaban Revenue and Market Share by Regions (2011-2016)
2.4 Global Rivaroxaban (Volume) by Application

3 USA RIVAROXABAN (VOLUME, VALUE AND SALES PRICE)

3.1 USA Rivaroxaban Sales and Value (2011-2016)
  3.1.1 USA Rivaroxaban Sales and Growth Rate (2011-2016)
  3.1.2 USA Rivaroxaban Revenue and Growth Rate (2011-2016)
  3.1.3 USA Rivaroxaban Sales Price Trend (2011-2016)
3.2 USA Rivaroxaban Sales and Market Share by Manufacturers
3.3 USA Rivaroxaban Sales and Market Share by Type
3.4 USA Rivaroxaban Sales and Market Share by Application

4 CHINA RIVAROXABAN (VOLUME, VALUE AND SALES PRICE)

4.1 China Rivaroxaban Sales and Value (2011-2016)
  4.1.1 China Rivaroxaban Sales and Growth Rate (2011-2016)
  4.1.2 China Rivaroxaban Revenue and Growth Rate (2011-2016)
  4.1.3 China Rivaroxaban Sales Price Trend (2011-2016)
4.2 China Rivaroxaban Sales and Market Share by Manufacturers
4.3 China Rivaroxaban Sales and Market Share by Type
4.4 China Rivaroxaban Sales and Market Share by Application

5 EUROPE RIVAROXABAN (VOLUME, VALUE AND SALES PRICE)

5.1 Europe Rivaroxaban Sales and Value (2011-2016)
  5.1.1 Europe Rivaroxaban Sales and Growth Rate (2011-2016)
  5.1.2 Europe Rivaroxaban Revenue and Growth Rate (2011-2016)
  5.1.3 Europe Rivaroxaban Sales Price Trend (2011-2016)
5.2 Europe Rivaroxaban Sales and Market Share by Manufacturers
5.3 Europe Rivaroxaban Sales and Market Share by Type
5.4 Europe Rivaroxaban Sales and Market Share by Application

6 JAPAN RIVAROXABAN (VOLUME, VALUE AND SALES PRICE)

6.1 Japan Rivaroxaban Sales and Value (2011-2016)
  6.1.1 Japan Rivaroxaban Sales and Growth Rate (2011-2016)
  6.1.2 Japan Rivaroxaban Revenue and Growth Rate (2011-2016)
  6.1.3 Japan Rivaroxaban Sales Price Trend (2011-2016)
6.2 Japan Rivaroxaban Sales and Market Share by Manufacturers
6.3 Japan Rivaroxaban Sales and Market Share by Type
6.4 Japan Rivaroxaban Sales and Market Share by Application

7 INDIA RIVAROXABAN (VOLUME, VALUE AND SALES PRICE)

7.1 India Rivaroxaban Sales and Value (2011-2016)
  7.1.1 India Rivaroxaban Sales and Growth Rate (2011-2016)
  7.1.2 India Rivaroxaban Revenue and Growth Rate (2011-2016)
  7.1.3 India Rivaroxaban Sales Price Trend (2011-2016)
7.2 India Rivaroxaban Sales and Market Share by Manufacturers
7.3 India Rivaroxaban Sales and Market Share by Type
7.4 India Rivaroxaban Sales and Market Share by Application

8 SOUTHEAST ASIA RIVAROXABAN (VOLUME, VALUE AND SALES PRICE)

8.1 Southeast Asia Rivaroxaban Sales and Value (2011-2016)
  8.1.1 Southeast Asia Rivaroxaban Sales and Growth Rate (2011-2016)
  8.1.2 Southeast Asia Rivaroxaban Revenue and Growth Rate (2011-2016)
  8.1.3 Southeast Asia Rivaroxaban Sales Price Trend (2011-2016)
8.2 Southeast Asia Rivaroxaban Sales and Market Share by Manufacturers
8.3 Southeast Asia Rivaroxaban Sales and Market Share by Type
8.4 Southeast Asia Rivaroxaban Sales and Market Share by Application

9 GLOBAL RIVAROXABAN MANUFACTURERS ANALYSIS

9.1 Pfizer, Inc. (US)
  9.1.1 Company Basic Information, Manufacturing Base and Competitors
  9.1.2 Rivaroxaban Product Type, Application and Specification
    9.1.2.1 Type I
    9.1.2.2 Type II
  9.1.3 Pfizer, Inc. (US) Rivaroxaban Sales, Revenue, Price and Gross Margin (2011-2016)
  9.1.4 Main Business/Business Overview
9.2 Bayer Healthcare AG (Germany)
  9.2.1 Company Basic Information, Manufacturing Base and Competitors
  9.2.2 128 Product Type, Application and Specification
    9.2.2.1 Type I
    9.2.2.2 Type II
  9.2.3 Bayer Healthcare AG (Germany) Rivaroxaban Sales, Revenue, Price and Gross Margin (2011-2016)
  9.2.4 Main Business/Business Overview
9.3 GlaxoSmithKline Plc. (UK)
  9.3.1 Company Basic Information, Manufacturing Base and Competitors
  9.3.2 142 Product Type, Application and Specification
    9.3.2.1 Type I
    9.3.2.2 Type II
  9.3.3 GlaxoSmithKline Plc. (UK) Rivaroxaban Sales, Revenue, Price and Gross Margin (2011-2016)
  9.3.4 Main Business/Business Overview
9.4 Boehringer Ingelheim (Germany)
  9.4.1 Company Basic Information, Manufacturing Base and Competitors
  9.4.2 Sept Product Type, Application and Specification
    9.4.2.1 Type I
    9.4.2.2 Type II
  9.4.3 Boehringer Ingelheim (Germany) Rivaroxaban Sales, Revenue, Price and Gross Margin (2011-2016)
  9.4.4 Main Business/Business Overview
9.5 Sanofi S.A. (France)
  9.5.1 Company Basic Information, Manufacturing Base and Competitors
  9.5.2 Product Type, Application and Specification
    9.5.2.1 Type I
    9.5.2.2 Type II
  9.5.3 Sanofi S.A. (France) Rivaroxaban Sales, Revenue, Price and Gross Margin (2011-2016)
  9.5.4 Main Business/Business Overview
9.6 Abbott India Limited (India)
  9.6.1 Company Basic Information, Manufacturing Base and Competitors
  9.6.2 Million USD Product Type, Application and Specification
    9.6.2.1 Type I
    9.6.2.2 Type II
  9.6.3 Abbott India Limited (India) Rivaroxaban Sales, Revenue, Price and Gross Margin (2011-2016)
  9.6.4 Main Business/Business Overview
9.7 Aspen Holdings (South Africa)
  9.7.1 Company Basic Information, Manufacturing Base and Competitors
  9.7.2 Pharma & Healthcare Product Type, Application and Specification
    9.7.2.1 Type I
    9.7.2.2 Type II
  9.7.3 Aspen Holdings (South Africa) Rivaroxaban Sales, Revenue, Price and Gross Margin (2011-2016)
  9.7.4 Main Business/Business Overview
9.8 Bristol-Myers Squibb Company (US)
  9.8.1 Company Basic Information, Manufacturing Base and Competitors
  9.8.2 Product Type, Application and Specification
    9.8.2.1 Type I
    9.8.2.2 Type II
  9.8.3 Bristol-Myers Squibb Company (US) Rivaroxaban Sales, Revenue, Price and Gross Margin (2011-2016)
  9.8.4 Main Business/Business Overview
9.9 Eisai Inc. (US)
  9.9.1 Company Basic Information, Manufacturing Base and Competitors
  9.9.2 Product Type, Application and Specification
    9.9.2.1 Type I
    9.9.2.2 Type II
  9.9.3 Eisai Inc. (US) Rivaroxaban Sales, Revenue, Price and Gross Margin (2011-2016)
  9.9.4 Main Business/Business Overview
9.10 Mitsubishi Tanabe Pharma Corporation (Japan)
  9.10.1 Company Basic Information, Manufacturing Base and Competitors
  9.10.2 Product Type, Application and Specification
    9.10.2.1 Type I
    9.10.2.2 Type II
  9.10.3 Mitsubishi Tanabe Pharma Corporation (Japan) Rivaroxaban Sales, Revenue, Price and Gross Margin (2011-2016)
  9.10.4 Main Business/Business Overview
9.11 Teva Pharmaceutical Industries Ltd. (Israel)

10 RIVAROXABAN MAUFACTURING COST ANALYSIS

10.1 Rivaroxaban Key Raw Materials Analysis
  10.1.1 Key Raw Materials
  10.1.2 Price Trend of Key Raw Materials
  10.1.3 Key Suppliers of Raw Materials
  10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
  10.2.1 Raw Materials
  10.2.2 Labor Cost
  10.2.3 Manufacturing Process Analysis of Rivaroxaban

11 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

11.1 Rivaroxaban Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Rivaroxaban Major Manufacturers in 2015
11.4 Downstream Buyers

12 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

12.1 Marketing Channel
  12.1.1 Direct Marketing
  12.1.2 Indirect Marketing
  12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
  12.2.1 Pricing Strategy
  12.2.2 Brand Strategy
  12.2.3 Target Client
12.3 Distributors/Traders List

13 MARKET EFFECT FACTORS ANALYSIS

13.1 Technology Progress/Risk
  13.1.1 Substitutes Threat
  13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change

14 GLOBAL RIVAROXABAN MARKET FORECAST (2016-2021)

14.1 Global Rivaroxaban Sales, Revenue Forecast (2016-2021)
14.2 Global Rivaroxaban Sales Forecast by Regions (2016-2021)
14.3 Global Rivaroxaban Sales Forecast by Type (2016-2021)
14.4 Global Rivaroxaban Sales Forecast by Application (2016-2021)

15 APPENDIX

Author List
Disclosure Section
Research Methodology
Data Source
China Disclaimer

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Rivaroxaban
Table Classification of Rivaroxaban
Figure Global Sales Market Share of Rivaroxaban by Type in 2015
Figure Type I Picture
Figure Type II Picture
Table Applications of Rivaroxaban
Figure Global Sales Market Share of Rivaroxaban by Application in 2015
Figure Application 1 Examples
Figure Application 2 Examples
Figure USA Rivaroxaban Revenue and Growth Rate (2011-2021)
Figure China Rivaroxaban Revenue and Growth Rate (2011-2021)
Figure Europe Rivaroxaban Revenue and Growth Rate (2011-2021)
Figure Japan Rivaroxaban Revenue and Growth Rate (2011-2021)
Figure India Rivaroxaban Revenue and Growth Rate (2011-2021)
Figure Southeast Asia Rivaroxaban Revenue and Growth Rate (2011-2021)
Figure Global Rivaroxaban Sales and Growth Rate (2011-2021)
Figure Global Rivaroxaban Revenue and Growth Rate (2011-2021)
Table Global Rivaroxaban Sales of Key Manufacturers (2011-2016)
Table Global Rivaroxaban Sales Share by Manufacturers (2011-2016)
Figure 2015 Rivaroxaban Sales Share by Manufacturers
Figure 2016 Rivaroxaban Sales Share by Manufacturers
Table Global Rivaroxaban Revenue by Manufacturers (2011-2016)
Table Global Rivaroxaban Revenue Share by Manufacturers (2011-2016)
Table 2015 Global Rivaroxaban Revenue Share by Manufacturers
Table 2016 Global Rivaroxaban Revenue Share by Manufacturers
Table Global Rivaroxaban Sales and Market Share by Type (2011-2016)
Table Global Rivaroxaban Sales Share by Type (2011-2016)
Figure Sales Market Share of Rivaroxaban by Type (2011-2016)
Figure Global Rivaroxaban Sales Growth Rate by Type (2011-2016)
Table Global Rivaroxaban Revenue and Market Share by Type (2011-2016)
Table Global Rivaroxaban Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Rivaroxaban by Type (2011-2016)
Figure Global Rivaroxaban Revenue Growth Rate by Type (2011-2016)
Table Global Rivaroxaban Sales and Market Share by Regions (2011-2016)
Table Global Rivaroxaban Sales Share by Regions (2011-2016)
Figure Sales Market Share of Rivaroxaban by Regions (2011-2016)
Figure Global Rivaroxaban Sales Growth Rate by Regions (2011-2016)
Table Global Rivaroxaban Revenue and Market Share by Regions (2011-2016)
Table Global Rivaroxaban Revenue Share by Regions (2011-2016)
Figure Revenue Market Share of Rivaroxaban by Regions (2011-2016)
Figure Global Rivaroxaban Revenue Growth Rate by Regions (2011-2016)
Table Global Rivaroxaban Sales and Market Share by Application (2011-2016)
Table Global Rivaroxaban Sales Share by Application (2011-2016)
Figure Sales Market Share of Rivaroxaban by Application (2011-2016)
Figure Global Rivaroxaban Sales Growth Rate by Application (2011-2016)
Figure USA Rivaroxaban Sales and Growth Rate (2011-2016)
Figure USA Rivaroxaban Revenue and Growth Rate (2011-2016)
Figure USA Rivaroxaban Sales Price Trend (2011-2016)
Table USA Rivaroxaban Sales by Manufacturers (2011-2016)
Table USA Rivaroxaban Market Share by Manufacturers (2011-2016)
Table USA Rivaroxaban Sales by Type (2011-2016)
Table USA Rivaroxaban Market Share by Type (2011-2016)
Table USA Rivaroxaban Sales by Application (2011-2016)
Table USA Rivaroxaban Market Share by Application (2011-2016)
Figure China Rivaroxaban Sales and Growth Rate (2011-2016)
Figure China Rivaroxaban Revenue and Growth Rate (2011-2016)
Figure China Rivaroxaban Sales Price Trend (2011-2016)
Table China Rivaroxaban Sales by Manufacturers (2011-2016)
Table China Rivaroxaban Market Share by Manufacturers (2011-2016)
Table China Rivaroxaban Sales by Type (2011-2016)
Table China Rivaroxaban Market Share by Type (2011-2016)
Table China Rivaroxaban Sales by Application (2011-2016)
Table China Rivaroxaban Market Share by Application (2011-2016)
Figure Europe Rivaroxaban Sales and Growth Rate (2011-2016)
Figure Europe Rivaroxaban Revenue and Growth Rate (2011-2016)
Figure Europe Rivaroxaban Sales Price Trend (2011-2016)
Table Europe Rivaroxaban Sales by Manufacturers (2011-2016)
Table Europe Rivaroxaban Market Share by Manufacturers (2011-2016)
Table Europe Rivaroxaban Sales by Type (2011-2016)
Table Europe Rivaroxaban Market Share by Type (2011-2016)
Table Europe Rivaroxaban Sales by Application (2011-2016)
Table Europe Rivaroxaban Market Share by Application (2011-2016)
Figure Japan Rivaroxaban Sales and Growth Rate (2011-2016)
Figure Japan Rivaroxaban Revenue and Growth Rate (2011-2016)
Figure Japan Rivaroxaban Sales Price Trend (2011-2016)
Table Japan Rivaroxaban Sales by Manufacturers (2011-2016)
Table Japan Rivaroxaban Market Share by Manufacturers (2011-2016)
Table Japan Rivaroxaban Sales by Type (2011-2016)
Table Japan Rivaroxaban Market Share by Type (2011-2016)
Table Japan Rivaroxaban Sales by Application (2011-2016)
Table Japan Rivaroxaban Market Share by Application (2011-2016)
Figure India Rivaroxaban Sales and Growth Rate (2011-2016)
Figure India Rivaroxaban Revenue and Growth Rate (2011-2016)
Figure India Rivaroxaban Sales Price Trend (2011-2016)
Table India Rivaroxaban Sales by Manufacturers (2011-2016)
Table India Rivaroxaban Market Share by Manufacturers (2011-2016)
Table India Rivaroxaban Sales by Type (2011-2016)
Table India Rivaroxaban Market Share by Type (2011-2016)
Table India Rivaroxaban Sales by Application (2011-2016)
Table India Rivaroxaban Market Share by Application (2011-2016)
Figure Southeast Asia Rivaroxaban Sales and Growth Rate (2011-2016)
Figure Southeast Asia Rivaroxaban Revenue and Growth Rate (2011-2016)
Figure Southeast Asia Rivaroxaban Sales Price Trend (2011-2016)
Table Southeast Asia Rivaroxaban Sales by Manufacturers (2011-2016)
Table Southeast Asia Rivaroxaban Market Share by Manufacturers (2011-2016)
Table Southeast Asia Rivaroxaban Sales by Type (2011-2016)
Table Southeast Asia Rivaroxaban Market Share by Type (2011-2016)
Table Southeast Asia Rivaroxaban Sales by Application (2011-2016)
Table Southeast Asia Rivaroxaban Market Share by Application (2011-2016)
Table Pfizer, Inc. (US) Basic Information List
Table Pfizer, Inc. (US) Rivaroxaban Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Pfizer, Inc. (US) Rivaroxaban Global Market Share (2011-2016)
Table Bayer Healthcare AG (Germany) Basic Information List
Table Bayer Healthcare AG (Germany) Rivaroxaban Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Bayer Healthcare AG (Germany) Rivaroxaban Global Market Share (2011-2016)
Table GlaxoSmithKline Plc. (UK) Basic Information List
Table GlaxoSmithKline Plc. (UK) Rivaroxaban Sales, Revenue, Price and Gross Margin (2011-2016)
Figure GlaxoSmithKline Plc. (UK) Rivaroxaban Global Market Share (2011-2016)
Table Boehringer Ingelheim (Germany) Basic Information List
Table Boehringer Ingelheim (Germany) Rivaroxaban Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Boehringer Ingelheim (Germany) Rivaroxaban Global Market Share (2011-2016)
Table Sanofi S.A. (France) Basic Information List
Table Sanofi S.A. (France) Rivaroxaban Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Sanofi S.A. (France) Rivaroxaban Global Market Share (2011-2016)
Table Abbott India Limited (India) Basic Information List
Table Abbott India Limited (India) Rivaroxaban Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Abbott India Limited (India) Rivaroxaban Global Market Share (2011-2016)
Table Aspen Holdings (South Africa) Basic Information List
Table Aspen Holdings (South Africa) Rivaroxaban Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Aspen Holdings (South Africa) Rivaroxaban Global Market Share (2011-2016)
Table Bristol-Myers Squibb Company (US) Basic Information List
Table Bristol-Myers Squibb Company (US) Rivaroxaban Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Bristol-Myers Squibb Company (US) Rivaroxaban Global Market Share (2011-2016)
Table Eisai Inc. (US) Basic Information List
Table Eisai Inc. (US) Rivaroxaban Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Eisai Inc. (US) Rivaroxaban Global Market Share (2011-2016)
Table Mitsubishi Tanabe Pharma Corporation (Japan) Basic Information List
Table Mitsubishi Tanabe Pharma Corporation (Japan) Rivaroxaban Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Mitsubishi Tanabe Pharma Corporation (Japan) Rivaroxaban Global Market Share (2011-2016)
Table Teva Pharmaceutical Industries Ltd. (Israel) Basic Information List
Table Teva Pharmaceutical Industries Ltd. (Israel) Rivaroxaban Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Teva Pharmaceutical Industries Ltd. (Israel) Rivaroxaban Global Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Rivaroxaban
Figure Manufacturing Process Analysis of Rivaroxaban
Figure Rivaroxaban Industrial Chain Analysis
Table Raw Materials Sources of Rivaroxaban Major Manufacturers in 2015
Table Major Buyers of Rivaroxaban
Table Distributors/Traders List
Figure Global Rivaroxaban Sales and Growth Rate Forecast (2016-2021)
Figure Global Rivaroxaban Revenue and Growth Rate Forecast (2016-2021)
Table Global Rivaroxaban Sales Forecast by Regions (2016-2021)
Table Global Rivaroxaban Sales Forecast by Type (2016-2021)
Table Global Rivaroxaban Sales Forecast by Application (2016-2021)